Doctors seek early warning signs for chemo heart damage
NCT ID NCT06511388
Summary
This study aims to find early markers that can predict which sarcoma patients are most at risk for heart damage from chemotherapy. Researchers will use advanced heart imaging techniques to monitor 400 patients receiving standard doxorubicin treatment at Mayo Clinic. The goal is to identify heart problems earlier so doctors can better protect patients during cancer treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.